Inspire Medical Systems (INSP) Cash & Equivalents (2017 - 2026)

Inspire Medical Systems (INSP) has 10 years of Cash & Equivalents data on file, last reported at $98.9 million in Q1 2026.

• For the quarter ending Q1 2026, Cash & Equivalents rose 83.61% year-over-year to $98.9 million; the trailing twelve-month figure through Mar 2026 stood at $98.9 million (up 83.61% YoY), and the FY2025 full-year result was $104.8 million, down 30.19% from the prior year.
• Cash & Equivalents declined to $98.9 million in Q1 2026, from $104.8 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $467.1 million in Q2 2023 to a low of $53.9 million in Q1 2025.
• A 5-year average of $224.3 million and a median of $185.5 million in 2023 frame the typical range for Cash & Equivalents.
• Across the five-year window, Cash & Equivalents jumped 150.34% in 2023 and tumbled 69.28% in 2025, its largest moves.
• Tracing INSP's Cash & Equivalents over 5 years: stood at $441.6 million in 2022, then sank by 57.98% to $185.5 million in 2023, then declined by 19.07% to $150.2 million in 2024, then plunged by 30.19% to $104.8 million in 2025, then retreated by 5.61% to $98.9 million in 2026.
• Business Quant data shows INSP's Cash & Equivalents at $98.9 million in Q1 2026, $104.8 million in Q4 2025, and $112.8 million in Q3 2025.